Skip to content
healthcare.dev
Get a free key

emtricitabine

NDC 69097-642, emtricitabine, capsule, from Cipla USA Inc..

Product NDC
69097-642
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091168
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-642 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EMTRICITABINE200 mg/1

Pharmacologic classes

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]

Package NDCNDC-11Package
69097-642-026909706420230 CAPSULE in 1 BOTTLE (69097-642-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a229c922-58eb-4795-9219-6cebb1779e35

  • NADAC price for package 69097064202

    GET /v1/drugs/nadac/69097064202

Use it

Look up 69097-642 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-642 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-642. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.